These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21998569)

  • 1. Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2011 Oct; 7(10):e1002179. PubMed ID: 21998569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2009 Aug; 5(8):e1000487. PubMed ID: 19714203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.
    Tse A; Verkhivker GM
    J Chem Inf Model; 2015 Aug; 55(8):1645-62. PubMed ID: 26236953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications.
    Astl L; Verkhivker GM
    J Chem Theory Comput; 2019 May; 15(5):3362-3380. PubMed ID: 31017783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational and Experimental Characterization of Patient Derived Mutations Reveal an Unusual Mode of Regulatory Spine Assembly and Drug Sensitivity in EGFR Kinase.
    Ruan Z; Katiyar S; Kannan N
    Biochemistry; 2017 Jan; 56(1):22-32. PubMed ID: 27936599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-world networks of residue interactions in the Abl kinase complexes with cancer drugs: topology of allosteric communication pathways can determine drug resistance effects.
    Tse A; Verkhivker GM
    Mol Biosyst; 2015 Jul; 11(7):2082-95. PubMed ID: 25996455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
    James KA; Verkhivker GM
    PLoS One; 2014; 9(11):e113488. PubMed ID: 25427151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
    Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Mutation-Induced Allosteric Changes in Structures and Conformational Ensembles of the ABL Kinase Using AlphaFold2 Adaptations with Alanine Sequence Scanning.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic view of the energy landscape in the allosteric regulation of Abl kinase.
    Saleh T; Rossi P; Kalodimos CG
    Nat Struct Mol Biol; 2017 Nov; 24(11):893-901. PubMed ID: 28945248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the allosteric inhibition of Abl kinase.
    Fallacara AL; Tintori C; Radi M; Schenone S; Botta M
    J Chem Inf Model; 2014 May; 54(5):1325-38. PubMed ID: 24787133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing conformational landscapes and mechanisms of allosteric communication in the functional states of the ABL kinase domain using multiscale simulations and network-based mutational profiling of allosteric residue potentials.
    Krishnan K; Tian H; Tao P; Verkhivker GM
    J Chem Phys; 2022 Dec; 157(24):245101. PubMed ID: 36586979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.
    Tse A; Verkhivker GM
    PLoS One; 2016; 11(11):e0166583. PubMed ID: 27861609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of Abelson kinase regulation by its αI-helix.
    Paladini J; Maier A; Habazettl JM; Hertel I; Sonti R; Grzesiek S
    Elife; 2024 Apr; 12():. PubMed ID: 38588001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations and modelling of the residue interaction networks in the BRAF kinase complexes with small molecule inhibitors: probing the allosteric effects of ligand-induced kinase dimerization and paradoxical activation.
    Verkhivker GM
    Mol Biosyst; 2016 Oct; 12(10):3146-65. PubMed ID: 27481329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.
    Fulton MD; Hanold LE; Ruan Z; Patel S; Beedle AM; Kannan N; Kennedy EJ
    Bioorg Med Chem; 2018 Mar; 26(6):1167-1173. PubMed ID: 28911855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors.
    Panjarian S; Iacob RE; Chen S; Wales TE; Engen JR; Smithgall TE
    J Biol Chem; 2013 Mar; 288(9):6116-29. PubMed ID: 23303187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Mechanisms of Communication Switching in the Hsp90-Cdc37 Regulatory Complexes with Client Kinases through Allosteric Coupling of Phosphorylation Sites: Perturbation-Based Modeling and Hierarchical Community Analysis of Residue Interaction Networks.
    Stetz G; Astl L; Verkhivker GM
    J Chem Theory Comput; 2020 Jul; 16(7):4706-4725. PubMed ID: 32492340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.